CIK 0001447028
- Non-accelerated filer
- Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980597776
- Phone
- +1 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-11 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $10.00 | $100K | 1,503,403 |
| 2018-07-09 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $8.91 | $89K | 1,513,403 |
| 2018-07-06 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $8.45 | $85K | 1,523,403 |
| 2018-07-05 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $8.40 | $84K | 1,533,403 |
| 2018-07-03 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $8.00 | $80K | 1,543,403 |
| 2018-06-19 | HENRIQUES RICHARD C JR Director | Grant or award · Director Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2018-06-19 | CONRAD HERBERT J Director | Grant or award · Director Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2018-06-19 | MANCHESTER KEITH S Director | Grant or award · Director Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2018-06-19 | Ramaswamy Vivek Director | Grant or award · Director Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2018-06-19 | BURGESS DANIEL D Director | Grant or award · Director Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2018-06-19 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-04-17 | Murray Mark J. President & CEO | Option exercise | +27,007 | $0.35 | $10K | 316,396 |
| 2018-04-17 | Murray Mark J. President & CEO | Option exercise · Employee Stock Option (Right to Buy) | −27,007 | 0 | ||
| 2018-04-16 | Sofia Michael J. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2018-04-16 | Murray Mark J. President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +418,187 | 418,187 | ||
| 2018-04-16 | VandenEnden Koert Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-04-16 | Symonds William T. Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-04-16 | Howard Elizabeth Exec. VP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-01-12 | SVF Investments (UK) Ltd 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2018-01-12 | Dexxon Holdings Ltd. 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
Page 9 of 12 · 239 trades